PD-1 inhibition in advanced myeloproliferative neoplasmsGabriela Hobbs, John Mascarenhas, Cansu Cimen Bozkus et al.|Blood Advances|2021Cited by 43
Mucin 1 is a potential therapeutic target in cutaneous T-cell lymphomaSalvia Jain, David Avigan, Dina Stroopinsky et al.|Blood|2015Cited by 37
MUC1 Inhibition Overcomes Chemotherapy Resistance in Acute Myeloid LeukemiaMyrna Nahas, Jacalyn Rosenblatt, Dina Stroopinsky et al.|Blood|2015Cited by 2
A compelling case for central pathology review of multiparameter flow cytometry measurable residual disease results in Acute Myeloid Leukemia (AML) clinical trials: Data from the PALG-AML1/2016 multicenter randomized studyAgnieszka Wierzbowska, Gail J. Roboz, Katarzyna Dulik et al.|Blood|2025Cited by 1
Characterization of antecedent clonal hematopoiesis (CH) mutations in lymphoid and plasma cell neoplasmsPinkal Desai, Gail J. Roboz, Zichan Li et al.|Blood|2025Cited by 1